Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary glomus tumour of the pituitary gland: diagnostic challenges of a rare and potentially aggressive neoplasm.
Quah BL, Donofrio CA, La Rosa S, Brouland JP, Cossu G, Djoukhadar I, Mayers H, Shenjere P, Pereira M, Pathmanaban ON, Murtaza MO, Gattamaneni R, Roncaroli F, Karabatsou K. Quah BL, et al. Among authors: gattamaneni r. Virchows Arch. 2021 May;478(5):977-984. doi: 10.1007/s00428-020-02923-4. Epub 2020 Sep 12. Virchows Arch. 2021. PMID: 32918169 Free PMC article.
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee. Grundy RG, et al. Among authors: gattamaneni r. Lancet Oncol. 2007 Aug;8(8):696-705. doi: 10.1016/S1470-2045(07)70208-5. Lancet Oncol. 2007. PMID: 17644039
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Batchelor TT, Mulholland P, Neyns B, Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S, Ashby LS, Degroot J, Gattamaneni R, Cher L, Rosenthal M, Payer F, Jürgensmeier JM, Jain RK, Sorensen AG, Xu J, Liu Q, van den Bent M. Batchelor TT, et al. Among authors: gattamaneni r. J Clin Oncol. 2013 Sep 10;31(26):3212-8. doi: 10.1200/JCO.2012.47.2464. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23940216 Free PMC article. Clinical Trial.
Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial.
Saran F, Welsh L, James A, McBain C, Gattamaneni R, Jefferies S, Harris F, Pemberton K, Schaible J, Bender S, Cseh A, Brada M. Saran F, et al. Among authors: gattamaneni r. J Neurooncol. 2021 Dec;155(3):307-317. doi: 10.1007/s11060-021-03877-6. Epub 2021 Nov 17. J Neurooncol. 2021. PMID: 34787778 Free PMC article. Clinical Trial.
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.
Taylor P, Rajendram R, Hanna S, Wilson V, Pell J, Li C, Cook A, Gattamaneni R, Plowman N, Jackson S, Hills R, French R, Uddin JM, Lee RWJ, Dayan CM. Taylor P, et al. Among authors: gattamaneni r. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2615-2625. doi: 10.1210/clinem/dgad084. J Clin Endocrinol Metab. 2023. PMID: 36971324 Free PMC article. Clinical Trial.
Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial.
Rajendram R, Lee RW, Potts MJ, Rose GE, Jain R, Olver JM, Bremner F, Hurel S, Cook A, Gattamaneni R, Tomlinson M, Plowman N, Bunce C, Hollinghurst SP, Kingston L, Jackson S, Dick AD, Rumsey N, Morris OC, Dayan CM, Uddin JM. Rajendram R, et al. Among authors: gattamaneni r. Trials. 2008 Jan 31;9:6. doi: 10.1186/1745-6215-9-6. Trials. 2008. PMID: 18237441 Free PMC article.
12 results